日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer

RET 抑制可克服 ER+ 乳腺癌对 CDK4/6 抑制剂和内分泌疗法的耐药性

Charlotte K Kindt, Sidse Ehmsen, Sofie Traynor, Benedetta Policastro, Nikoline Nissen, Mie K Jakobsen, Monique F Hundebøl, Lene E Johansen, Martin Bak, Elsa Arbajian, Johan Staaf, Henrik J Ditzel, Carla L Alves

Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor

针对 PI3K、ER 和 CDK4/6 的三联疗法可抑制对氟维司群和 CDK4/6 或 PI3K 抑制剂耐药的 ER 阳性乳腺癌的生长。

Karimi, Leena; Alves, Carla L; Terp, Mikkel G; Tuttolomondo, Martina; Portman, Neil; Ehmsen, Sidse; Johansen, Lene E; Bak, Martin; Lim, Elgene; Ditzel, Henrik J

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer

共同靶向 CDK2 和 CDK4/6 可克服 ER+ 乳腺癌对芳香化酶和 CDK4/6 抑制剂的耐药性

Abeer J Al-Qasem #, Carla L Alves #, Sidse Ehmsen, Martina Tuttolomondo, Mikkel G Terp, Lene E Johansen, Henriette Vever, Luna V A Hoeg, Daniel Elias, Martin Bak, Henrik J Ditzel

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

出版商更正:CDK4/6 和 AKT 与内分泌疗法联合靶向可阻止 CDK4/6 抑制剂和内分泌疗法耐药性乳腺癌的进展

Alves, Carla L; Ehmsen, Sidse; Terp, Mikkel G; Portman, Neil; Tuttolomondo, Martina; Gammelgaard, Odd L; Hundebøl, Monique F; Kaminska, Kamila; Johansen, Lene E; Bak, Martin; Honeth, Gabriella; Bosch, Ana; Lim, Elgene; Ditzel, Henrik J

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

CDK4/6 和 AKT 与内分泌疗法共同靶向可阻止 CDK4/6 抑制剂和内分泌疗法耐药性乳腺癌的进展

Carla L Alves, Sidse Ehmsen #, Mikkel G Terp #, Neil Portman, Martina Tuttolomondo, Odd L Gammelgaard, Monique F Hundebøl, Kamila Kaminska, Lene E Johansen, Martin Bak, Gabriella Honeth, Ana Bosch, Elgene Lim, Henrik J Ditzel

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit

MCM3 上调导致乳腺癌产生内分泌抵抗,并且是他莫昔芬疗效减弱的预测标志

Sanne Løkkegaard, Daniel Elias, Carla L Alves, Martin V Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F Gjerstorff, Lene E Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S Lindström, Laura J Esserman, Anne E Lykkesfeldt, Jens S

Prioritizing the Mental Health and Well-Being of Healthcare Workers: An Urgent Global Public Health Priority

优先保障医护人员的心理健康和福祉:一项紧迫的全球公共卫生要务

Søvold, Lene E; Naslund, John A; Kousoulis, Antonis A; Saxena, Shekhar; Qoronfleh, M Walid; Grobler, Christoffel; Münter, Lars

Quantifying the variability between multiple multiplanar reconstructions of computed tomography scans

量化计算机断层扫描多平面重建之间的变异性

Miles, James E; Buelund, Lene E

MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas

MGMT 基因启动子甲基化状态 - 评估两种焦磷酸测序试剂盒和三种甲基化特异性 PCR 方法对胶质母细胞瘤的预测能力

Lene E Johannessen, Petter Brandal, Tor Åge Myklebust, Sverre Heim, Francesca Micci, Ioannis Panagopoulos

Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma

脑膜瘤中MGMT启动子甲基化的焦磷酸测序分析

Panagopoulos, Ioannis; Gorunova, Ludmila; Leske, Henning; Niehusmann, Pitt; Johannessen, Lene E; Staurseth, Julie; Øino, Nina; Meling, Torstein R; Heim, Sverre; Micci, Francesca; Brandal, Petter